TMOD-31. NOVEL HETEROGENEOUS GLIOBLASTOMA MODELS TO OPTIMIZE HUMAN TUMORICIDAL NEURAL STEM CELL THERAPY

Tumor-homing neural stem cell (NSC) therapy is a promising new strategy that recently entered human patient testing for glioblastoma (GBM). The success of NSCs in the clinic will depend on their ability to overcome the heterogeneity and invasiveness of patient GBM, and the development of preclinical...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Neuro Oncol
Päätekijät: Satterlee, Andrew, Dunn, Denise, Hagler, Shaye, Lo, Donald, Hingtgen, Shawn
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2018
Aiheet:
Abstracts
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6216681/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.1143
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia